홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
IBRX
#1043
ImmunityBio, Inc. Common Stock
7.6
0
USD
+4.11%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.11%
월간 변동
-10.80%
6달 변화
+202.79%
년간 변동율
+154.18%
이전 종가
7.3
0
Open
7.6
0
Bid
Ask
Low
7.6
0
High
7.6
0
양
103
마켓
주식
헬스케어
IBRX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.96 B
4.15 B
2.37 B
2.31 B
10.68 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
-9.77
-4.26
-4.54
-3.67
-3.64
-6.31
EBITDA 비율에 대한 기업 가치
—
-7.08
-5.92
-9.5
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
-0.61
-0.74
-1.15
-1.16
-1.08
-0.7
-0.91
Return on equity %
-0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
-406.35
-499.19
-255.38
-327.6
-630.3
-482.51
-477.16
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
-82.55 K
-35.36 K
-146.37 K
-58.24 K
-2 334.23
-226
-1 002.3
EBITDA margin %
-74.31 K
-33.84 K
-138.77 K
-55.26 K
-2 215.18
68.17
308.16
Net margin %
-83.23 K
-37.13 K
-173.57 K
-93.76 K
-2 804.77
-310.18
-1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
-0.04
1.75
0.85
0.73
3.4
Debt to equity ratio
—
—
0.03
-1.5
-0.67
-0.73
-2.6
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
0.14
-1.43
-0.58
-0.65
-2.29
Per share metrics
Operating cash flow per share
—
-0.71
-0.84
-0.72
-0.56
-0.33
-0.34
EBIT per share
—
-0.85
-0.88
-0.71
-0.49
-0.28
-0.28
EBITDA per share
—
-0.81
-0.83
-0.68
-0.47
0.08
0.1
Total debt per share
—
—
-0.03
1.73
0.47
0.4
1.56
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
-0.63
-1.17
-1.19
-0.72
-0.56
-2.5
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
-0.62
-1.12
-1.15
-0.7
-0.54
-2.43
뉴스
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)
ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26% - TipRanks.com
ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy
ImmunityBio Crashes On FDA Warning Over Anktiva Claims - ImmunityBio (NASDAQ:IBRX)
Can Anktiva's Label Expansion Unlock the Next Growth Phase for IBRX?
ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion